|
|||||
|
|
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role |
|
| Affiliation: | 2. TIMI Study Group, Cardiovascular Medicine, Brigham and Women''s Hospital, Boston, MA;4. Jacksonville Center For Clinical Research, Jacksonville, FL;11. IRCM, University of Montreal, Montreal, QC, Canada;8. Amgen Inc., Thousand Oaks, CA;112. Metabolic and Atherosclerosis Research Center, Cincinnati, OH |
| Abstract: | |
| Keywords: | lipoprotein (a) low density lipoprotein cholesterol low density lipoprotein receptor proprotein convertase subtilisin/kexin type 9 |
| 本文献已被 ScienceDirect 等数据库收录！ | |